BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 2157033)

  • 1. Effects of atrial and brain natriuretic peptides upon cyclic GMP levels, potassium transport, and receptor binding in rat astrocytes.
    Beaumont K; Tan PK
    J Neurosci Res; 1990 Feb; 25(2):256-62. PubMed ID: 2157033
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial natriuretic peptide receptor subtypes in rat neuronal and astrocyte glial cultures.
    Sumners C; Tang W
    Am J Physiol; 1992 May; 262(5 Pt 1):C1134-43. PubMed ID: 1317098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of atrial and brain natriuretic peptides to cultured mouse astrocytes from different brain regions and effect on cyclic GMP production.
    Yeung VT; Ho SK; Leung DH; Stadlin A; Nicholls MG; Cockram CS
    Glia; 1993 Dec; 9(4):243-7. PubMed ID: 7509312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of atrial natriuretic peptide receptors in brain microvessel endothelial cells.
    Whitson PA; Huls MH; Sams CF
    J Cell Physiol; 1991 Jan; 146(1):43-51. PubMed ID: 1846636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat renal preglomerular vessels, glomeruli and papillae do not express detectable quantities of B-type natriuretic peptide receptor.
    de Leon H; Bonhomme MC; Garcia R
    J Hypertens; 1994 May; 12(5):539-48. PubMed ID: 7930554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype.
    Mimeault M; Fournier A; Féthiere J; De Léan A
    Mol Pharmacol; 1993 May; 43(5):775-82. PubMed ID: 8502232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced affinity of iodinated forms of Tyr0 C-type natriuretic peptide for rat natriuretic peptide receptor B.
    Thibault G; Grove KL; Deschepper CF
    Mol Pharmacol; 1995 Dec; 48(6):1046-53. PubMed ID: 8848004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atrial and brain natriuretic peptides share binding sites on cultured cells from the rat trachea.
    James S; Burnstock G
    Cell Tissue Res; 1991 Sep; 265(3):555-65. PubMed ID: 1838497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional analysis of natriuretic peptide receptors in the bladder of the toad, Bufo marinus.
    Meier SK; Donald JA
    Gen Comp Endocrinol; 2002 Feb; 125(2):207-17. PubMed ID: 11884066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of brain and atrial natriuretic peptides to cultured mouse astrocytes and effect on cyclic GMP.
    Yeung VT; Lai CK; Cockram CS; Young JD; Nicholls MG
    J Neurochem; 1991 May; 56(5):1684-9. PubMed ID: 1849550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultracytochemical localization of particulate guanylate cyclase after stimulation with natriuretic peptides in lamb olfactory mucosa.
    Spreca A; Rambotti MG
    Histochem J; 1994 Oct; 26(10):778-86. PubMed ID: 7883588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Localization of receptors for natriuretic peptide and endothelin in the duct of the epididymis of the freshwater turtle.
    Kim SZ; Kang SY; Lee SJ; Cho KW
    Gen Comp Endocrinol; 2000 Apr; 118(1):26-38. PubMed ID: 10753564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apparent B-type natriuretic peptide selectivity in the kidney due to differential processing.
    Kishimoto I; Hamra FK; Garbers DL
    Can J Physiol Pharmacol; 2001 Aug; 79(8):715-22. PubMed ID: 11558680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of C-type natriuretic peptide on rat astrocytes: regional differences and characterization of receptors.
    Deschepper CF; Picard S
    J Neurochem; 1994 May; 62(5):1974-82. PubMed ID: 7908948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological profile of HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin. I. Selective inhibition of the actions of natriuretic peptides in anesthetized rats.
    Sano T; Morishita Y; Matsuda Y; Yamada K
    J Pharmacol Exp Ther; 1992 Feb; 260(2):825-31. PubMed ID: 1346647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological evidence for the heterogeneity of atrial natriuretic factor-R1 receptor subtype.
    Féthière J; De Léan A
    Mol Pharmacol; 1991 Dec; 40(6):915-22. PubMed ID: 1684636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of natriuretic peptides on ventricular myocyte contraction and role of cyclic GMP signaling.
    Zhang Q; Moalem J; Tse J; Scholz PM; Weiss HR
    Eur J Pharmacol; 2005 Mar; 510(3):209-15. PubMed ID: 15763244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
    Cahill PA; Hassid A
    J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-type natriuretic peptide and atrial natriuretic peptide receptors of rat brain.
    Brown J; Zuo Z
    Am J Physiol; 1993 Mar; 264(3 Pt 2):R513-23. PubMed ID: 8096124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide interacts with atrial natriuretic peptide receptor in cultured rat vascular smooth muscle cells.
    Hirata Y; Shichiri M; Emori T; Marumo F; Kangawa K; Matsuo H
    FEBS Lett; 1988 Oct; 238(2):415-8. PubMed ID: 2844607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.